# MANP in Hypertension and Metabolic Syndrome

> **NCT03781739** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 22 (actual)

## Conditions studied

- Hypertension
- Metabolic Syndrome

## Interventions

- **DRUG:** MANP

## Key facts

- **NCT ID:** NCT03781739
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-18
- **Primary completion:** 2019-11-14
- **Final completion:** 2019-12-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03781739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03781739, "MANP in Hypertension and Metabolic Syndrome". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT03781739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*